Abdul J. Sankoh

6.1k total citations · 4 hit papers
41 papers, 2.5k citations indexed

About

Abdul J. Sankoh is a scholar working on Statistics and Probability, Molecular Biology and Biological Psychiatry. According to data from OpenAlex, Abdul J. Sankoh has authored 41 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Statistics and Probability, 7 papers in Molecular Biology and 7 papers in Biological Psychiatry. Recurrent topics in Abdul J. Sankoh's work include Statistical Methods in Clinical Trials (13 papers), Tryptophan and brain disorders (7 papers) and Optimal Experimental Design Methods (7 papers). Abdul J. Sankoh is often cited by papers focused on Statistical Methods in Clinical Trials (13 papers), Tryptophan and brain disorders (7 papers) and Optimal Experimental Design Methods (7 papers). Abdul J. Sankoh collaborates with scholars based in United States, Netherlands and Belgium. Abdul J. Sankoh's co-authors include Mohammad F. Huque, Stephen Kanes, Jeffrey M. Jonas, Haihong Li, Ralph B. D’Agostino, Samantha Meltzer‐Brody, Kristina M. Deligiannidis, Robert Riesenberg, David R. Rubinow and Anna Legedza and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Neurology.

In The Last Decade

Abdul J. Sankoh

40 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Some comments on frequently used multiple endpoint adjustment methods in clinical trials

1997 693 citations Abdul J. Sankoh, Mohammad F. Huque et al. Statistics in Medicine profile →
Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection

2011 566 citations Kenneth E. Sherman, Steven L. Flamm et al. New England Journal of Medicine profile →
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials

2018 407 citations Samantha Meltzer‐Brody, Helen Colquhoun et al. The Lancet profile →
Effect of Zuranolone vs Placebo in Postpartum Depression

2021 149 citations Kristina M. Deligiannidis, Samantha Meltzer‐Brody et al. JAMA Psychiatry profile →

Peers

Countries citing papers authored by Abdul J. Sankoh

Since Specialization

Citations

This map shows the geographic impact of Abdul J. Sankoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdul J. Sankoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdul J. Sankoh more than expected).

Fields of papers citing papers by Abdul J. Sankoh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdul J. Sankoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdul J. Sankoh. The network helps show where Abdul J. Sankoh may publish in the future.

Co-authorship network of co-authors of Abdul J. Sankoh

This figure shows the co-authorship network connecting the top 25 collaborators of Abdul J. Sankoh. A scholar is included among the top collaborators of Abdul J. Sankoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdul J. Sankoh. Abdul J. Sankoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dalzanemdor (SAGE‐718), a novel, investigational N‐methyl‐D‐aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose‐finding studies in healthy participants and an open‐label study in participants with Huntington's disease 2024 ·Clinical and Translational Science ·Aaron Koenig, Michael Lewis, (unknown), Sigui Li, (unknown), Jing Dai, Abdul J. Sankoh, (unknown), James Doherty, (unknown)	9
2	Zuranolone in Major Depressive Disorder 2023 ·The Journal of Clinical Psychiatry ·Anita H. Clayton, Robert Lasser, Indrani Nandy, Abdul J. Sankoh, Jeffrey M. Jonas, Stephen Kanes	50
3	Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder 2022 ·Journal of Affective Disorders ·Ellison Suthoff, Mark Kosinski, (unknown), Paul Hodgkins, Handan Gunduz‐Bruce, Robert Lasser, Christopher Silber, Abdul J. Sankoh, Haihong Li, Brian Werneburg, Jeffrey M. Jonas, James Doherty, Stephen Kanes, Vijayveer Bonthapally	19
4	Effect of Zuranolone vs Placebo in Postpartum Depression breakdown → 2021 ·JAMA Psychiatry ·Kristina M. Deligiannidis, Samantha Meltzer‐Brody, Handan Gunduz‐Bruce, James Doherty, Jeffrey M. Jonas, Sigui Li, Abdul J. Sankoh, Christopher Silber, Andrew Campbell, Brian Werneburg, Stephen Kanes, Robert Lasser	149
5	Mechanistic PK/PD Model of Neuroactive Steroid GABAA Positive Allosteric Modulation and Effects on TETRAS Assessment in Essential Tremor (4499) 2020 ·Neurology ·David P. Nguyen, Anne C. Smith, (unknown), E. Hoffman, James Paskavitz, Angela Wehr, (unknown), Amy Bullock, Abdul J. Sankoh, Albert J. Robichaud, Stephen Kanes, James Doherty, Michael C. Quirk	1
6	SAGE-217 in Major Depressive Disorder: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial (705) 2020 ·Neurology ·(unknown), Anita H. Clayton, Robert Lasser, Indrani Nandy, Abdul J. Sankoh, Andrew D. Campbell, Brian Werneburg, Christopher Silber, (unknown), (unknown), Handan Gunduz-Bruce	1
7	Brexanolone Injection in Postpartum Depression: Two Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Trials 2019 ·Obstetrical & Gynecological Survey ·Samantha Meltzer‐Brody, Helen Colquhoun, Robert Riesenberg, C. Neill Epperson, Kristina M. Deligiannidis, David R. Rubinow, Haihong Li, Abdul J. Sankoh, Christine Clemson, (unknown), Jeffrey M. Jonas, Stephen Kanes	1
8	Trial of SAGE-217 in Patients with Major Depressive Disorder 2019 ·New England Journal of Medicine ·Handan Gunduz-Bruce, Christopher Silber, Inder Kaul, Anthony J. Rothschild, Robert Riesenberg, Abdul J. Sankoh, Haihong Li, Robert Lasser, Charles F. Zorumski, David R. Rubinow, Steven M. Paul, Jeffrey M. Jonas, James Doherty, Stephen Kanes	161
9	SAGE-217, A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies 2019 ·Clinical Pharmacokinetics ·Ethan Hoffmann, George G. Nomikos, Inder Kaul, Shane Raines, (unknown), Amy Bullock, Abdul J. Sankoh, James Doherty, Stephen Kanes, Helen Colquhoun	45
10	Health-related quality of life in a Phase 2, randomized, placebo-controlled trial of the GABA(A)R modulator SAGE-217 in major depressive disorder 2019 ·European Neuropsychopharmacology ·Vijayveer Bonthapally, Handan Gunduz-Bruce, Christopher Silber, Anthony J. Rothschild, (unknown), Abdul J. Sankoh, (unknown), (unknown), Ellison Suthoff, Charles F. Zorumski, David R. Rubinow, Steven M. Paul, (unknown), J. Doherty, Stephen Kanes	1
11	Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials breakdown → 2018 ·The Lancet ·Samantha Meltzer‐Brody, Helen Colquhoun, Robert Riesenberg, C. Neill Epperson, Kristina M. Deligiannidis, David R. Rubinow, Haihong Li, Abdul J. Sankoh, Christine Clemson, (unknown), Jeffrey M. Jonas, Stephen Kanes	407
12	PMH76 - PATIENT REPORTED MEASURES OF DEPRESSIVE SYMPTOMS AND FATIGUE IN A PHASE 2, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF THE GABAA RECEPTOR POSITIVE ALLOSTERIC MODULATOR SAGE-217 IN MAJOR DEPRESSIVE DISORDER 2018 ·Value in Health ·Vijayveer Bonthapally, Ellison Suthoff, P. Hodgkins, Handan Gunduz-Bruce, Robert Lasser, Christopher Silber, Abdul J. Sankoh, (unknown), (unknown), J. Doherty, (unknown)	1
13	SAGE-217 in subjects with major depressive disorder: efficacy and safety results from open-label Part A of a phase 2A study 2017 ·European Neuropsychopharmacology ·Handan Gunduz-Bruce, Robert Riesenberg, Abdul J. Sankoh, (unknown), George G. Nomikos, J. Doherty, Inder Kaul, (unknown), (unknown), Stephen Kanes	2
14	75. A Single-Ascending Dose Study of the Neuroactive Steroid SAGE-217 2017 ·Biological Psychiatry ·Stephen Kanes, George G. Nomikos, Michael C. Quirk, Shane Raines, James Doherty, Ethan Hoffmann, Abdul J. Sankoh, Helen Colquhoun	1
15	Evaluation of Overall Treatment Effect in MMRM 2013 ·Journal of Biopharmaceutical Statistics ·Tao Song, Qunming Dong, Abdul J. Sankoh, Geert Molenberghs	4
16	Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection breakdown → 2011 ·New England Journal of Medicine ·Kenneth E. Sherman, Steven L. Flamm, Nezam H. Afdhal, David R. Nelson, Mark Sulkowski, Gregory T. Everson, Michael Fried, Michael Adler, Hendrik W. Reesink, (unknown), Abdul J. Sankoh, Nathalie Adda, Robert S. Kauffman, Shelley George, Christopher I. Wright, Fred Poordad	566
17	A note on the conservativeness of the confidence interval approach for the selection of non‐inferiority margin in the two‐arm active‐control trial 2008 ·Statistics in Medicine ·Abdul J. Sankoh	5
18	Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues 2003 ·Statistics in Medicine ·Abdul J. Sankoh, Ralph B. D’Agostino, Mohammad F. Huque	86
19	ON THE UTILITY OF THE DIRICHLET DISTRIBUTION FOR META-ANALYSIS OF CLINICAL STUDIES 1999 ·Journal of Biopharmaceutical Statistics ·Abdul J. Sankoh, Mohamed Alosh, Mohammad F. Huque	2
20	Some comments on frequently used multiple endpoint adjustment methods in clinical trials breakdown → 1997 ·Statistics in Medicine ·Abdul J. Sankoh, Mohammad F. Huque, (unknown)	693

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact